CF
LXRX icon

Corebridge Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

Corebridge Financial’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-56,248
Closed -$25.9K – 1581
2025
Q1 		$25.9K Sell
56,248
-834
-1% -$526 ﹤0.01% 2866
2024
Q4 		$42.2K Sell
57,082
-4,309
-7% -$5.19K ﹤0.01% 2865
2024
Q3 		$96.4K Sell
61,391
-379
-0.6% -$675 ﹤0.01% 2632
2024
Q2 		$104K Buy
+61,770
New +$111K ﹤0.01% 2583

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corebridge Financial's LXRX Position: Q2 2025 in Review

Corebridge Financial sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2025, closing a stake of 56,248 shares — an estimated $25.9K sold.

Corebridge Financial first reported a position in LXRX in Q2 2024 and held it in 4 quarters. The position peaked at $104K in Q2 2024. 123 funds tracked by Wall St. Rank hold LXRX as of Q2 2025.

  • Corebridge Financial reported no remaining Lexicon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 56,248 Lexicon Pharmaceuticals shares in Q2 2025, an estimated $25.9K.
  • Corebridge Financial first reported a position in Lexicon Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Lexicon Pharmaceuticals position peaked at $104K in Q2 2024.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.